关于治疗非小细胞肺癌 (NSCLC) 的最新情况
1Department of Clinical Laboratory Sciences, Collage of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia.
Journal of clinical medicine
|October 16, 2025
概括
本综述审查了已完成第四阶段试验的非小细胞肺癌 (NSCLC) 的先进疗法. 它强调了有前途的治疗方法,如免疫检查点抑制剂和组合疗法,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 占所有肺癌病例的85-90%.
- 目前对NSCLC的治疗策略需要进一步的证据和优化.
研究的目的:
- 评估已成功通过第四阶段临床试验的NSCLC疗法的疗效和不良影响.
- 探索新和组合治疗方法,以改善NSCLC的管理.
主要方法:
- 对NSCLC治疗的第四阶段试验数据的系统审查.
- 对特定药物的分析,包括达科米提尼布,洛拉提尼布,杜尔瓦卢马布,奥西默提尼布和里瓦罗克萨班.
- 评估包括免疫检查点抑制剂,血液静止和化疗在内的组合疗法.
主要成果:
- 免疫检查点抑制剂表现出特定活性,副作用最小.
- 组合疗法显示了未来NSCLC治疗策略的潜力.
- 现有疗法需要进一步的研究,以提高安全性和疗效.
结论:
- 先进的疗法,特别是免疫检查点抑制剂和组合策略,为NSCLC治疗提供了有前途的途径.
- 持续的研究对于完善现有治疗方法和开发创新的方法来改善患者长期治疗结果至关重要.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.9K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
11.0K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
